Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib
A Yin, GDM Veerman, JGC van Hasselt… - CPT …, 2024 - Wiley Online Library
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib.
A Yin, GD Veerman, JGC van Hasselt… - CPT …, 2024 - search.ebscohost.com
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib
A Yin, GD Veerman, JGC van Hasselt… - CPT: Pharmacometrics …, 2024 - diva-portal.org
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib.
A Yin, GDM Veerman, JGC van Hasselt… - CPT …, 2024 - europepmc.org
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib
A Yin, GDM Veerman… - CPT …, 2024 - pubmed.ncbi.nlm.nih.gov
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
[HTML][HTML] Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib
A Yin, GDM Veerman, JGC van Hasselt… - CPT …, 2024 - ncbi.nlm.nih.gov
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
[PDF][PDF] Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib
A Yin, GDM Veerman, JGC van Hasselt… - 2024 - pure.eur.nl
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
[PDF][PDF] Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib
A Yin, GDM Veerman, JGC van Hasselt… - 2024 - pure.eur.nl
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib.
A Yin, GDM Veerman, JGC van Hasselt… - CPT …, 2024 - europepmc.org
Insight into the development of treatment resistance can support the optimization of
anticancer treatments. This study aims to characterize the tumor dynamics and development …
anticancer treatments. This study aims to characterize the tumor dynamics and development …